• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 18.60
  • VXN 23.66
  • VXO 18.16
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
Refresh      
PRGO (Perrigo Company plc)
Last Trade 44.805 Dividend/Share 0.76 PE Ratio 9.24
Date 12:16:17 PM Dividend Yield 1.662 Return on Assets 1.08
Change -0.395 ExDividend Date 2018-11-29 Return on Capital null
Bid 44.83 Latest EPS 0.84 Price/Sale 1.756
Ask 44.99 LatestEPS Date 2017-12-31 Price to Book 1.1
Volume 3629 EPS ttm 4.850 Institutional % 137.7
Avg Volume 2.2M Shares Outstanding 135.86M Insider % 0.6
Open 45.37 Float 135M Short Ratio 2.270
Prev Close 45.2 Return On Equity 2.1 5 Year Change % -0.704
High 45.62 Consensus EPS 1 2 Year Change % -0.398
Low 44.985 No. of Estimate 12.000 1 Year Change % -0.497
52 Week High 95.93 EPS Surprise $ null YTD Change % 0.116
52 Week Low 36.28 EPS Surprise Percent 0 6 Month Change % -0.394
52 Week Change -49.676 EBITDA 0M 3 Month Change % -0.369
50 Day MA 57.22665 Revenue 0M 1 Month Change % -0.207
200 Day MA Gross Profit 0M 5 Day Change % 0.023
Market Cap 6140.72M Cash 0M 30 Day Change % -0.274
Beta 1.235354 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 5474515
Short Date 2018-12-31 Revenue Per Employee 0 Short Ratio 2.270
Data courtesy of IEX
12
Company Profile

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets generic prescription drug products, including creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquid suspensions, and solutions, as well as nasal sprays, oral liquids, and transdermal products. The API segment engages in the development, manufacture, and marketing of APIs used by the generic drug industry and branded pharmaceutical companies. Perrigo Company also manufactures and markets branded prescription drugs; and imports pharmaceutical, diagnostics, and other medical products. The company has collaborative agreements with Medicis Pharmaceutical Corporation, Medimetriks Pharmaceuticals, Cobrek Pharmaceuticals, and Cephalon Inc. Its customers primarily include retail drug companies, supermarkets, wholesalers, chain drug stores, hospitals and hospital systems, mass merchandise chains, and group purchasing organizations. The company was founded in 1887 and is headquartered in Allegan, Michigan.